Literature DB >> 16502263

Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells.

M Flahaut1, A Mühlethaler-Mottet, K Auderset, K Balmas Bourloud, R Meier, M Beck Popovic, J M Joseph, N Gross.   

Abstract

Neuroblastoma represents the most common and deadly solid tumour of childhood, which disparate biological and clinical behaviour can be explained by differential regulation of apoptosis. To understand mechanisms underlying death resistance in neuroblastoma cells, we developed small hairpin of RNA produced by lentiviral vectors as tools to selectively interfere with FLIP(L), a major negative regulator of death receptor-induced apoptosis. Such tools revealed highly efficient in interfering with FLIP(L) expression and function as they almost completely repressed endogenous and/or exogenously overexpressed FLIP(L) protein and fully reversed FLIP(L)-mediated TRAIL resistance. Moreover, interference with endogenous FLIP(L) and FLIP(S) significantly restored FasL sensitivity in SH-EP neuroblastoma cell line. These results reveal the ability of lentivirus-mediated shRNAs to specifically and persistently interfere with FLIP expression and support involvement of FLIP in the regulation of death receptor-mediated apoptosis in neuroblastoma cells. Combining such tools with other therapeutic modalities may improve treatment of resistant tumours such as neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502263     DOI: 10.1007/s10495-006-3435-9

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  10 in total

1.  Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.

Authors:  Sudeshna Seal; David M Hockenbery; Emily Y Spaulding; Hans-Peter Kiem; Nissa Abbassi; H Joachim Deeg
Journal:  Exp Hematol       Date:  2008-10-05       Impact factor: 3.084

2.  Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.

Authors:  A Mühlethaler-Mottet; M Flahaut; K Balmas Bourloud; K Nardou; A Coulon; J Liberman; M Thome; N Gross
Journal:  Cell Death Dis       Date:  2011-03-03       Impact factor: 8.469

3.  Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.

Authors:  Annick Mühlethaler-Mottet; Marjorie Flahaut; Katia Balmas Bourloud; Katya Auderset; Roland Meier; Jean-Marc Joseph; Nicole Gross
Journal:  BMC Cancer       Date:  2006-08-24       Impact factor: 4.430

4.  NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.

Authors:  P Ruggeri; L Cappabianca; A R Farina; L Gneo; A R Mackay
Journal:  Cell Death Discov       Date:  2016-02-01

5.  Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.

Authors:  Marjorie Flahaut; Nicolas Jauquier; Nadja Chevalier; Katya Nardou; Katia Balmas Bourloud; Jean-Marc Joseph; David Barras; Christian Widmann; Nicole Gross; Raffaele Renella; Annick Mühlethaler-Mottet
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

6.  TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.

Authors:  Luciana Gneo; Pierdomenico Ruggeri; Lucia Cappabianca; Antonietta Rosella Farina; Natalia Di Ianni; Andrew Reay Mackay
Journal:  Oncotarget       Date:  2016-12-06

7.  Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.

Authors:  Gilda Raguénez; Annick Mühlethaler-Mottet; Roland Meier; Caroline Duros; Jean Bénard; Nicole Gross
Journal:  BMC Cancer       Date:  2009-03-30       Impact factor: 4.430

8.  Expression and biological significance of c-FLIP in human hepatocellular carcinomas.

Authors:  Xilin Du; Guoqiang Bao; Xianli He; Huadong Zhao; Fang Yu; Qing Qiao; Jianguo Lu; Qingjiu Ma
Journal:  J Exp Clin Cancer Res       Date:  2009-02-20

9.  The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.

Authors:  Roland Meier; Annick Mühlethaler-Mottet; Marjorie Flahaut; Aurélie Coulon; Carlo Fusco; Fawzia Louache; Katya Auderset; Katia Balmas Bourloud; Estelle Daudigeos; Curzio Ruegg; Gilles Vassal; Nicole Gross; Jean-Marc Joseph
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

10.  Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.

Authors:  Annick Mühlethaler-Mottet; Roland Meier; Marjorie Flahaut; Katia Balmas Bourloud; Katya Nardou; Jean-Marc Joseph; Nicole Gross
Journal:  Mol Cancer       Date:  2008-06-12       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.